Answers are grounded in this paper and cite their sources.
This survey aimed to assess the current capacity of primary healthcare (PHC) institutions in China to diagnose and treat Chronic obstructive pulmonary disease (COPD), based on respondents’ reports. An online questionnaire covering professional staffing, diagnostic testing, equipment and medication availability, screening implementation, long-term patient management and smoking cessation services was distributed through the Peking University General Practice Research Network, the Chinese General Practice Research Network, and the Standardized Respiratory Care System and Capacity-Building Project from January to July 2025. The questionnaire respondents in this study were drawn from PHC institutions, secondary hospitals, and tertiary hospitals. Because tertiary hospitals differ considerably from PHC institutions and secondary hospitals, tertiary hospitals were excluded from the present analysis. A total of 918 questionnaires were collected. After excluding 8 questionnaires from institutions that could not be identified and 116 questionnaires from tertiary hospitals, 794 questionnaires remained for analysis. Of these, 762 (96.0%) were from PHC institutions and 32 (4.0%) were from secondary hospitals. The 794 valid questionnaires were completed by respondents from 357 institutions: 328 PHC institutions and 29 secondary hospitals. Among respondents from PHC institutions, 58.0% reported that their institution had personnel able to perform spirometry, 44.0% reported availability of portable or handheld spirometers and 59.1% reported provision of spirometry, but the median reported number of tests performed during the preceding 12 months was only 6. Several long-acting combination inhalers were less frequently reported as available by respondents from PHC institutions than by those from secondary hospitals. COPD screening was reported by 70.3% of respondents from PHC institutions; among these respondents, the median reported number of cases identified during the preceding 12 months was 20. A COPD specialty outpatient clinic was reported by 20.6% of respondents from PHC institutions, while the median reported numbers of newly diagnosed and managed patients were 1 and 30, respectively. A foundation has been laid for COPD diagnosis and treatment at PHC institutions in China; however, screening and medication availability need to be further strengthened to improve the quality of COPD management in PHC institutions.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: